Perfil
Rachel Meyers is the founder of Faze Medicines, Inc. She is currently an Independent Director at Korro Bio, Inc. since 2023.
Previously, she worked as a Senior Scientist at Millennium Pharmaceuticals, Inc. from 1993 to 2003.
Additionally, she held the position of Vice President-Research & RNAi Lead Discovery at Alnylam Pharmaceuticals, Inc. from 2011 to 2013.
Dr. Meyers obtained a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from Brandeis University.
Cargos activos de Rachel Meyers
| Empresas | Cargo | Inicio |
|---|
Antiguos cargos conocidos de Rachel Meyers.
| Empresas | Cargo | Fin |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2003 |
| Faze Medicines, Inc. | Fundador | - |
| ALNYLAM PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | - |
Formación de Rachel Meyers.
| Massachusetts Institute of Technology | Doctorate Degree |
| Brandeis University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| Faze Medicines, Inc. |
- Bolsa de valores
- Insiders
- Rachel Meyers